Life AI Net
홈
아카이브
계산기
디렉토리
뉴스레터
로그인
한국어
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
홈
아카이브
계산기
디렉토리
뉴스레터
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
로그인
홈
아카이브
계산기
디렉토리
More
실시간
Clinical OMICs
Unexpected Role for RNA Editing in Cancer Immune Evasion Uncovered
Clinical OMICs
Proactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome
Clinical OMICs
CAR T Success Hinges on Microenvironment Response in GBM
Endpoints News
FDA warns telehealth companies over compounded GLP-1s
BioPharma Dive
UniQure to file gene therapy for approval, reflecting major shifts at FDA
Endpoints News
UK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says
Endpoints News
Hackers claim they stole Novo Nordisk AI models, manufacturing recipes
Endpoints News
In second reversal, FDA gives uniQure a green light to seek accelerated approval
BioPharma Dive
Jazz zeroes in on next-gen T cell engagers with AbCellera deal
Clinical OMICs
Vibrating Pill Predicts Anorexia Relapse
FierceBiotech
Vedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapies
FierceBiotech
UniQure stock surges after FDA U-turn clears path to gene therapy filing
Clinical OMICs
Unexpected Role for RNA Editing in Cancer Immune Evasion Uncovered
Clinical OMICs
Proactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome
Clinical OMICs
CAR T Success Hinges on Microenvironment Response in GBM
Endpoints News
FDA warns telehealth companies over compounded GLP-1s
BioPharma Dive
UniQure to file gene therapy for approval, reflecting major shifts at FDA
Endpoints News
UK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says
Endpoints News
Hackers claim they stole Novo Nordisk AI models, manufacturing recipes
Endpoints News
In second reversal, FDA gives uniQure a green light to seek accelerated approval
BioPharma Dive
Jazz zeroes in on next-gen T cell engagers with AbCellera deal
Clinical OMICs
Vibrating Pill Predicts Anorexia Relapse
FierceBiotech
Vedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapies
FierceBiotech
UniQure stock surges after FDA U-turn clears path to gene therapy filing
아카이브
이 기사는 아카이브에서 찾을 수 없습니다.